Literature DB >> 5062826

Inflammatory myopathy with facioscapulohumeral distribution.

T L Munsat, D Piper, P Cancilla, J Mednick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5062826     DOI: 10.1212/wnl.22.4.335

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  27 in total

1.  Inflammatory changes in facioscapulohumeral muscular dystrophy.

Authors:  M Molnár; P Diószeghy; F Mechler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 2.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

3.  Linkage analysis in the spinal muscular atrophy type of facioscapulohumeral disease.

Authors:  T Siddique; H Roper; M A Pericak-Vance; J Shaw; K L Warner; W Y Hung; K L Phillips; P Lunt; W J Cumming; A D Roses
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

4.  Skeletal muscle expression of class II histocompatibility antigens (HLA-DR) in polymyositis and other muscle disorders with an inflammatory infiltrate.

Authors:  J A Zuk; A Fletcher
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

Review 5.  Facioscapulohumeral Dystrophy.

Authors:  Leo H Wang; Rabi Tawil
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

6.  Facioscapulohumeral dystrophy with myositis associated with rheumatoid arthritis.

Authors:  P C Coelho; F Morgado; P Reis; M V de Queiroz
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

7.  New method for the estimation of the number of motor units in a muscle. 2. Duchenne, limb-girdle and facioscapulohumeral, and myotonic muscular dystrophies.

Authors:  J P Ballantyne; S Hansen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-11       Impact factor: 10.154

8.  Familial myopathies with restricted distribution, facial weakness and inflammatory changes in affected muscles.

Authors:  M Bacq; N Telerman-Toppet; C Coërs
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

Review 9.  Drug treatment for facioscapulohumeral muscular dystrophy.

Authors:  M R Rose; R Tawil
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Inflammatory changes in affected muscles of facioscapulohumeral dystrophy.

Authors:  H Honda; Y Mano; A Takahashi
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.